Tumor and blood B-cell abundance outperforms established immune checkpoint blockade response prediction signatures in head and neck cancer.
Chang TG, Spathis A, Schäffer AA, Gavrielatou N, Kuo F, Jia D, Mukherjee S, Sievers C, Economopoulou P, Anastasiou M, Moutafi M, Pal LR, Vos J, Lee AS, Lam S, Zhao K, Jiang P, Allen CT, Foukas P, Gomatou G, Altan-Bonnet G, Morris LGT, Psyrri A, Ruppin E.
Chang TG, et al. Among authors: sievers c.
Ann Oncol. 2024 Nov 17:S0923-7534(24)04914-7. doi: 10.1016/j.annonc.2024.11.008. Online ahead of print.
Ann Oncol. 2024.
PMID: 39551185